Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

Are there signs the storm created by Donald Trump's tariffs could be calming? Global markets have rebounded following the US president's announcement of a 90-day pause on most tariffs, prompting ...

A 76-year-old woman says she’s stuck in Puerto Rico after Frontier Airlines wouldn’t let her fly back home to New York with her “emotional support” parrot. Maria Fraterrigo told CNN ...

Journalist E.A. Hanks shared that her father, actor Tom Hanks, and brother, Colin Hanks, were among the first to read her deeply personal new memoir, "The Ten: A Memoir of Family and the Open Road ...

I was moved by Niki Griswold’s article about Mayor Michelle Wu of Boston and her experiences bringing her baby along to work (“Wu and daughter are hard to miss,” Page A1, April 5).

people with overweight or obesity had lost 5.9% of overall body weight after 3 months of using semaglutide. And after 6 months, they had lost 10.9%. Do you lose weight on a maintenance dose of Wegovy?

Novo's Victoza (liraglutide) daily GLP-1 is already well established and the company hopes to build on its success with semaglutide and its more convenient weekly dosing schedule. Novo is also ...

When actress-turned-politician Smriti Irani shared her weight loss pictures, the internet was left stunned. Known for her powerful presence both on-screen and in Parliament, her transformation ...

Second lady Usha Vance described in a rare interview how a "switch flipped" in her and her husband J.D. Vance’s lives after he was chosen as President Donald Trump’s running mate, saying the ...

Between being sued for defamation for very publicly accusing her ex and three other men of running a child sexual assault ring, promoting a fake domestic violence hotline, and traveling the world ...

However, at the two-year, three-year, and four-year time points from the index date, those taking semaglutide had an increased risk for NAION (hazard ratios, 2.39, 2.44, and 2.05, respectively).